Jason T. Goodson

Dr. Jason T. Goodson


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2013 in Journal of Traumatic Stress
Verified
Journal Article
Closed access
PDF file
JGJason T. Goodson
Jason T. Goodson
CLCarin M. Lefkowitz
Carin M. Lefkowitz
AHAmy W. Helstrom
Amy W. Helstrom
MGMichael J. Gawrysiak
Michael J. Gawrysiak

26 May 2016 in Journal of Clinical Psychology
Verified
Journal Article
Closed access
PDF file
JGJason T. Goodson
Jason T. Goodson
GHGerald J. Haeffel
Gerald J. Haeffel
DRDavid A. Raush
David A. Raush
RHRachel Hershenberg
Rachel Hershenberg

30 April 2018 in Journal of Clinical Psychology
Verified
Journal Article
Closed access
PDF file
JGJason T. Goodson
Jason T. Goodson
GHGerald J. Haeffel
Gerald J. Haeffel

1 July 2022 in Clinical Psychology and Special Education
Verified
Journal Article
Open access
CLC.E. Lawlor
C.E. Lawlor
JGJason T. Goodson
Jason T. Goodson
GHGerald J. Haeffel
Gerald J. Haeffel
Depression is one of the most common, disabling, and lethal (e.g., suicide) forms of psychopathology. Nearly 300 million people struggle with depression worldwide, and it is the leading cause of disability for people ages 15-44. Unfortunately, most people with depression do not receive the treatment they need. There is limited access to mental health services, and when services are available, the treatments used tend to have limited scientific support. This is because many mental health professionals are not trained in empirically supported treatments, are ambivalent about the role of science in clinical practice, and have limited access to scientific research (e.g., journal paywalls). The purpose of this special issue article is to provide a free and easy to use primer on Cognitive Behavioral Therapy (CBT) for depression. CBT is the most studied form of psychotherapy, has a strong theoretical basis, can be implemented by therapists of varying experience levels, and is as effective or more effective than existing treatments, including medication. CBT may not work for every client, but it is the best place to start. In this article, we discuss: a) why CBT should be the first-line treatment for depression, b) the theoretical basis of CBT for depression, and c) a basic overview of how to administer 12 sessions of CBT for depression. We also provide a reading list and supplemental open-access materials (e.g., a cognitive skills workbook) for further education.

6 January 2025 in Journal of Veterans Studies
Verified
Journal Article
Open access
PDF file
JGJason T. Goodson
Jason T. Goodson
WPWarren Ponder
Warren Ponder
JCJose Carbajal
Jose Carbajal
CCClair Cassiello-Robbins
Clair Cassiello-Robbins
Combat veterans suffer from elevated rates of posttraumatic stress disorder (PTSD), depression, and generalized anxiety relative to the general population and other non-deployed veterans. Furthermore, many studies are currently evaluating the efficacy of interventions (e.g., cognitive processing therapy and prolonged exposure) with samples of combat veterans seeking mental health treatment at the US Department of Defense (DoD) and the US Department of Veterans Affairs (VA). However, a growing number of veterans are seeking mental health treatment outside of the VA/DoD as there have been long waiting times and a preference for group psychotherapy over individual one-on-one treatment. Moreover, the VA/DoD has mostly relied on manualized treatment approaches that often require a single “index event” when there are possibly more traumatic events that also need to be addressed. To fill this gap in the literature, this study used a community-based sample of treatment-seeking combat veterans (N = 68) who completed measures for PTSD (PTSD Checklist-5), depression (Beck Depression Inventory-II), and generalized anxiety (Beck Anxiety Inventory). We conducted a paired t-test to evaluate the efficacy of clinical services. The licensed clinicians used a non-manualized approach, such as cognitive behavioral therapy and narrative exposure, in a brief six-session course of treatment. Results showed statistically significant reductions in symptoms of PTSD, depression, and generalized anxiety from baseline to session 6. Combat veterans treated in a civilian community-based clinic showed significant benefits in a relatively brief course of treatment. These findings are encouraging and suggest that research should continue to explore evidence-based treatments for combat veterans.

1 July 2022 in Clinical Psychology and Special Education
Verified
Journal Article
Open access
JGJason T. Goodson
Jason T. Goodson
GHGerald J. Haeffel
Gerald J. Haeffel
PTSD is a chronic and disabling condition associated with psychiatric and medical comorbidity and diminished quality of life. Military Veterans are at increased risk for developing PTSD, and combat-related PTSD may be more difficult to treat than civilian PTSD. Both Prolonged Exposure and Cognitive Processing Therapy are empirically supported treatments for PTSD in military populations with a strong empirical foundation. However, they require considerable resources to implement and can be difficult for providers and patients to learn. To address these limitations, we created Behavioral Therapy for Anxiety and PTSD (BTAP), which is a simple, behavior-based therapy rooted in learning theory. Building on empirically established therapies such as Prolonged Exposure, BTAP has a singular focus on identifying, reducing, and countering safety behaviors that maintain PTSD. Because it only focuses on safety behaviors, it is simple to learn and implement; therapist trainings are one day, and follow-up consultation provided as needed. In this special issue article, we describe the BTAP protocol as well as provide real world case examples from Veterans to illustrate key components of the treatment. We also present data from five Veteran patients that demonstrate feasibility, acceptance, and preliminary evidence of effectiveness. Patients reported significant reductions in PTSD symptoms, depressive symptoms, intrusions, and safety behaviors. This work suggests that BTAP for treating PTSD merits further investigation.